Evaluation of platelet function during extended storage in additive solution, prepared in a new container that allows manual buffy-coat platelet pooling and leucoreduction in the same system

Blood Transfusion

Volumn 10, Issue 4, 2012, Pages 480-489

  Plaza, Eva María ^a   Lozano, María Luisa ^a   Guiu, Isabel Sánchez ^a   Egea, José Manuel ^b   Vicente, Vicente ^a   Collantes De Terán, Laura ^c   Rivera Pozo, José ^a  

^a UNIVERSITY OF MURCIA   (Spain)

^b HOSPITAL MORALES MESEGUER   (Spain)

^c Laboratorios Grifols SA   (Spain)

Author keywords

Buffy coat; Leucodepletion; Platelet; Pools; Storage

Indexed keywords

ARACHIDONIC ACID; BIOLOGICAL RESPONSE MODIFIER; CD63 ANTIGEN; COLLAGEN; FIBRINOGEN RECEPTOR; FRESH FROZEN PLASMA; GLYCOPROTEIN IB; PADGEM PROTEIN; RISTOCETIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE; THROMBOCYTE CONCENTRATE;

ARTICLE; BLOOD BUFFY COAT; BLOOD DONOR; BLOOD FILTRATION; CONTAINER; CYTOLYSIS; ERYTHROCYTE; FLOW CYTOMETRY; FUNCTIONAL STATUS; HEMATOCRIT; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOOSMOTIC STRESS; LEUKAPHERESIS; LEUKOCYTE COUNT; LIGAND BINDING; NORMAL HUMAN; PROTEIN EXPRESSION; SUPERNATANT; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTE MEMBRANE; THROMBOCYTE METABOLISM; THROMBOCYTE POOR PLASMA; THROMBOCYTE PRESERVATION; THROMBOCYTE VOLUME;

ANTIGENS, HUMAN PLATELET; BLOOD BUFFY COAT; BLOOD PLATELETS; BLOOD PRESERVATION; FEMALE; GENE EXPRESSION REGULATION; HUMANS; LEUKOCYTE REDUCTION PROCEDURES; MALE; PLATELET FUNCTION TESTS; TIME FACTORS;

EID: 84870037392     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2012.0112-11     Document Type: Article

References (51)

1. Council of Europe. European Directorate for the Quality of Medicines and HealthCare (EDQM). Guide to the preparation, use and quality assurance of blood components. Strasbourg: Council of Europe Pub; 2011.
2. Rivera J, Lozano ML, Vicente V. In vitro changes of platelet parameters during blood banking. Methods Mol Biol 2004; 273: 57-72.
3. Ahmed AS, Leheta O, Younes S. In vitro assessment of platelet storage lesion in leucoreduced random donor platelet concentrates. Blood Transfus 2010; 8: 28-35.
4. van der Meer P, Pietersz R, Reesink H. Leucoreduced platelet concentrates in additive solution: an evaluation of filters and storage containers. Vox Sang 2001; 81: 102-7. (Pubitemid 35369985)
5. Andreu G, Vasse J, Sandid I, et al. Use of random versus apheresis platelet concentrates. Transfus Clin Biol 2007; 14: 514-21.
6. Sullivan MT, Cotten R, Read EJ, Wallace EL. Blood collection and transfusion in the United States in 2001. Transfusion 2007; 47: 385-94.
7. Armstrong B, Hardwick J, Raman L, et al. Introduction to blood transfusion technology. Vox Sang ISBT Science Series 2008; 3: 165-7.
8. Janetzko K, Kluter H, van WG, Eichler H. Fully automated processing of buffy-coat-derived pooled platelet concentrates. Transfusion 2004; 44: 1052-8. (Pubitemid 38823813)
9. Larsson S, Sandgren P, Sjodin A, et al. Automated preparation of platelet concentrates from pooled buffy coats: in vitro studies and experiences with the OrbiSac system. Transfusion 2005; 45: 743-51. (Pubitemid 40656388)
10. Ringwald J, Zimmermann R, Eckstein R. The new generation of platelet additive solution for storage at 22 degrees C: development and current experience. Transfus Med Rev 2006; 20: 158-64.
11. Holme S, Moroff G, Murphy S. A multi-laboratory evaluation of in vitro platelet assays: the tests for extent of shape change and response to hypotonic shock. Transfusion 1998; 38: 31-40. (Pubitemid 28090937)
12. Jarvis GE. Platelet aggregation: turbidimetric measurements. Methods Mol Biol 2004; 272: 65-76.
13. Pérez-Ceballos E, Rivera J, Lozano ML, et al. Evaluation of refrigerated platelet concentrates supplemented with low doses of second messenger effectors. Clin Lab Haematol 2004; 26: 275-86. (Pubitemid 39070694)
14. Dijkstra-Tiekstra MJ, Kuipers W, Setroikromo AC, de Wildt-Eggen J. Platelet capacity of various platelet pooling systems for buffy coat-derived platelet concentrates. Transfusion 2008; 48: 2114-21.
15. Ohto H, Nollet KE. Overview on platelet preservation: better controls over storage lesion.Transfus Apher Sci 2011; 44: 321-5.
16. Rudderow D, Soslau G. Permanent lesions of stored platelets correlate to pH and cell count while reversible lesions do not. Proc Soc Exp Biol Med. 1998; 217: 219-27.
17. Kilkson H, Holme S, Murphy S. Platelet metabolism during storage of platelet concentrates at 22 degrees C. Blood. 1984; 64: 406-14. (Pubitemid 14051327)
18. Murphy S. Metabolic patterns of platelets - impact on storage for transfusion. Vox Sang 1994; 67 (Suppl. 3): 271-3. (Pubitemid 24234059)
19. Farrugia A. Platelet concentrates for transfusionmetabolic and storage aspects. Platelets 1994; 5: 177-85. (Pubitemid 24227012)
20. Bertolini F, Porretti L, Lauri E, et al. Role of lactate in platelet storage lesion. Vox Sang 1993; 65: 194-8. (Pubitemid 23291055)
21. Hornsey VS, McColl K, Drummond O, et al. Extended storage of platelets in SSP platelet additive solution. Vox Sang 2006; 91: 41-6. (Pubitemid 43822303)
22. van der Meer PF, Pietersz RN, Reesink HW. Storage of platelets in additive solution for up to 12 days with maintenance of good in-vitro quality. Transfusion 2004; 44: 1204-11. (Pubitemid 38989753)
23. Diedrich B, Sandgren P, Jansson B, et al. In vitro and in vivo effects of potassium and magnesium on storage up to 7 days of apheresis platelet concentrates in platelet additive solution. Vox Sang 2008; 94: 96-102.
24. Greco CA, Zhang JG, Kalab M, et al. Effect of platelet additive solution on bacterial dynamics and their influence on platelet quality in stored platelet concentrates. Transfusion 2010; 50: 2344-52.
25. Sandgren P, Callaert M, Shanwell A, Gulliksson H. Storage of platelet concentrates from pooled buffy coats made of fresh and overnight-stored whole blood processed on the novel Atreus 2C+ system: in vitro study. Transfusion 2008; 48: 688-96 (Pubitemid 351430341)
26. Dijkstra-Tiekstra MJ, van der Meer PF, Cardigan R, et al. Biomedical Excellence for Safer Transfusion Collaborative. Platelet concentrates from fresh or overnight-stored blood, an international study. Transfusion 2011; 51 (Suppl. 1): 38S-44S.
27. McShine RL, Weggemans M, Das PC, et al. The use of fresh plasma and a plasma-free medium to enhance the aggregation response of stored platelets. Platelets 1993; 4: 338-40. (Pubitemid 24146987)
28. Rivera J, Lozano ML, Navarro-Núñez L, Vicente V. Platelet receptors and signaling in the dynamics of thrombus formation. Haematologica 2009; 94: 700-11.
29. Keuren JF, Cauwenberghs S, Heeremans J, et al. Platelet ADP response deteriorates in synthetic storage media. Transfusion 2006; 46: 204-12. (Pubitemid 43381755)
30. Rendu F, Brohard-Bohn B. The platelet release reaction: granules' constituents, secretion and functions. Platelets 2001; 12: 261-73.
31. Kostelijk EH, Fijnheer R, Nieuwenhuis HK, et al. Soluble P-selectin as parameter for platelet activation during storage. Thromb Haemost 1996; 76: 1086-9.
32. Kyrle PA, Hron G, Eichinger S, Wagner O. Circulating p-selectin and the risk of recurrent venous thromboembolism.Thromb Haemost 2007; 97: 880-3.
33. Zhang JG, Carter CJ, Devine DV, et al. Comparison of a novel viscous platelet additive solution and plasma: preparation and in vitro storage parameters of buffycoat-derived platelet concentrates. Vox Sang 2008; 94: 299-305.
34. Sandgren P, Hild M, Sjodin A, Gulliksson H. Storage of buffy-coat-derived platelets in additive solutions: in vitro effects on platelets prepared by the novel TACSI system and stored in plastic containers with different gas permeability. Vox Sang 2010; 99: 341-7.
35. Heddle NM Febrile nonhemolytic transfusion reactions to platelets. Curr Opin Hematol. 1995; 2: 478-83.
36. Blumberg N, Phipps RP, Kaufman J, Heal JM. The causes and treatment of reactions to platelet transfusions. Transfusion 2003; 43: 291-2.
37. Ferrer F, Rivera J, Corral J, et al. Evaluation of leukocyte-depleted platelet concentrates obtained by in-line filtration. Vox Sang 2000; 78: 235-41.
38. Ferrer F, Rivera J, Corral J, et al. Evaluation of pooled platelet concentrates using prestorage versus poststorage WBC reduction: impact of filtration timing. Transfusion 2000; 40: 781-8.
39. Wakamoto S, Fujihara M, Kuzuma K, et al. Biologic activity of RANTES in apheresis PLT concentrates and its involvement in nonhemolytic transfusion reactions. Transfusion 2003; 43: 1038-46.
40. Klüter H, Bubel S, Kirchner H, Wilhelm D. Febrile and allergic transfusion reactions after the transfusion of white cell-poor platelet preparations. Transfusion 1999; 39: 1179-84.
41. Blumberg N, Spinelli SL, Francis CW, et al. The platelet as an immune cell--CD40 ligand and transfusion immunomodulation. Immunol Res 2009; doi: 10.1007/s12026-009-8106-9.
42. Khan SY, Kelher MR, Heal JM, et al. Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood 2006; 108: 2455-62.
43. Kaufman J, Spinelli SL, Schultz E, et al. Release of biologically active CD154 during collection and storage of platelet concentrates prepared for transfusion. J Thromb Haemost 2007; 5: 788-96.
44. Cognasse F, Payrat JM, Corash L, et al. Platelet components associated with acute transfusion reactions: the role of platelet-derived soluble CD40 ligand. Blood 2008; 112: 4779-80.
45. Blumberg N, Gettings KF, Turner C, et al. An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions. Transfusion 2006; 46: 1813-21.
46. Skripchenko A, Kurtz J, Moroff G, Wagner SJ. Platelet products prepared by different methods of sedimentation undergo platelet activation differently during storage. Transfusion 2008; 48: 469-77.
47. Wenzel F, Günther W, Baertl A, et al. Comparison of soluble CD40L concentrations and release capacities in apheresis and prestorage pooled platelet concentrates. Clin Hemorheol Microcirc 2011; 47: 269-78.
48. Cognasse F, Boussoulade F, Chavarin P, et al. Release of potential immunomodulatory factors during platelet storage. Transfusion 2006; 46: 1184-9.
49. Fast LD, Dileone G, Marschner S. Inactivation of human white blood cells in platelet products after pathogen reduction technology treatment in comparison to gamma irradiation. Transfusion 2011; 51: 1397-404.
50. Tanaka S, Hayashi T, Tani Y, Hirayama F. Removal by adsorbent beads of biological response modifiers released from platelets, accumulated during storage, and potentially associated with platelet transfusion reaction. Transfusion 2010; 50: 1096-105.
51. th ed. Bethesda, MD: American Association of Blood Banks, 2011.